Form 4: Ocular Therapeutix Executive Sells Shares
Insider Transaction (Form 4)
Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc, sold 10,869 shares of common stock on October 2, 2026 for $7.05 per share.
Summary
- Open-market sale: disposed of 10,869 Common Stock at $7.05 ($76,626) on October 2, 2026; holds 307,457 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $76,626 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jeffrey S. Heier — Officer (Chief Scientific Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Common Stock | 10,869 | $7 | $76.6K | 307,457 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (10,869 shares) |
Keywords
insider transaction, Form 4, OCUL, OCULAR THERAPEUTIX, INC, bearish, Jeffrey S. Heier
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.